STAGE IV PROSTATE CANCER
Clinical trials for STAGE IV PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Evolutionary strategy takes on advanced prostate cancer
Disease control OngoingThis study tests a two-step treatment plan for men with high-risk, stage IV prostate cancer that still responds to hormone therapy. The first step uses hormone therapy plus a newer drug, followed by chemotherapy plus hormone therapy. The goal is to see if this sequential approach…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 04:13 UTC
-
Promising prostate cancer combo under study
Disease control OngoingThis early-phase trial studies the safety and best way to give enzalutamide alongside radiation and hormone therapy for men with intermediate or high-risk prostate cancer. The goal is to see if this combination can better control the disease by blocking androgens that fuel cancer…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New hope for tough prostate cancer: targeted drug combo shows promise
Disease control OngoingThis study tests three treatment options for men with advanced prostate cancer that has stopped responding to hormone therapy and has specific DNA repair defects. Participants receive either abiraterone (a hormone-blocking drug), olaparib (a targeted drug), or both together. The …
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New adaptive hormone therapy aims to outsmart advanced prostate cancer
Disease control OngoingThis study tests an adaptive approach to hormone therapy for men with stage IV prostate cancer that still responds to hormone treatment. The goal is to control the cancer while possibly reducing side effects by adjusting treatment based on how the cancer responds. Only 17 men par…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New combo therapy aims to boost immune response in hard-to-treat prostate cancer
Disease control OngoingThis study looks at how well the hormone drug enzalutamide works alone or with a targeted radiation therapy (radium-223) in 30 men with advanced prostate cancer that has spread to bones and no longer responds to standard hormone treatment. The goal is to see changes in the cancer…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Prostate cancer drugs may cloud your mind – study investigates
Knowledge-focused OngoingThis study looks at how certain hormone therapies for advanced prostate cancer affect men's thinking skills, like memory and concentration. Researchers will use brain scans and thinking tests to see if these treatments cause changes in the brain. The goal is to understand why som…
Matched conditions: STAGE IV PROSTATE CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC